U-343 MG Cells

The U-343 MG cell line is derived from a human glioblastoma, a type of aggressive brain tumor. Originally isolated from a 54-year-old Caucasian male, this cell line has been widely used in neurological research, particularly in studies concerning the pathology and therapeutic treatment strategies for glioblastoma. The U-343 MG cell line is notable for its astrocytic properties, resembling those of astrocytes in the brain, which makes it particularly useful for studying tumor behavior and neurobiology in a controlled in vitro environment.

Genetically, the U-343 MG cells are characterized by various mutations typical of glioblastoma, including alterations in the TP53 gene and the EGFR gene. These mutations not only offer insights into the molecular underpinnings of glioblastoma malignancy but also serve as potential targets for therapeutic intervention. The cell line is also used to assess the cytotoxicity of drugs and to study the mechanisms of resistance that glioblastoma cells can develop. This makes U-343 MG a valuable model for evaluating the efficacy of new chemotherapeutic agents and for exploring novel treatment paradigms, such as targeted therapy and immunotherapy.